Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)

• Roy S Herbst,
• Naiyer Rizvi,
• Karen Kelly,
• Vassiliki A Papadimitrakopoulou,
• Natasha B Leighl,
• Mary W Redman,
• Fred R Hirsch,
• Philip C Mack,
• Lawrence H Schwartz,
• James L Wade,
• William J Irvin,
• Sreekanth C Reddy,
• Jeffrey Crawford,
• Jeffrey D Bradley,
• Thomas E Stinchcombe,
• Suresh S Ramalingam,
• Jieling Miao,
• Katherine Minichiello,
• David R Gandara

Affiliations

Roy S Herbst

Medical Oncology, Yale Cancer Center | Yale School of Medicine | Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA

Naiyer Rizvi

Thoracic Oncology, Columbia University Irving Medical Center, New York, New York, USA

Karen Kelly

Divison of Hematology and Oncology, Department of Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA

Vassiliki A Papadimitrakopoulou

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Natasha B Leighl

Division of Medical Oncology/Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada

Mary W Redman

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Fred R Hirsch

Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine Mount Sinai, New York, New York, USA

Philip C Mack

Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine Mount Sinai, New York, New York, USA

Lawrence H Schwartz

Department of Radiology, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, USA

James L Wade

Medical Oncology, Heartland NCORP, Decatur, Illinois, USA

William J Irvin

Hematology Oncology, Bon Secours Cancer Institute, Richmond, Virginia, USA

Sreekanth C Reddy

Medical Oncology/Hematology, Atlanta Cancer Care Centers, Atlanta, Georgia, USA

Jeffrey Crawford

Medical Oncology, Duke University Medical Center, Durham, North Carolina, USA

Jeffrey D Bradley

Department of Radiation Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA

Thomas E Stinchcombe

Medical Oncology, Duke University Medical Center, Durham, North Carolina, USA

Suresh S Ramalingam

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA

Jieling Miao

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Katherine Minichiello

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

David R Gandara

Division of Hematology/Oncology, Department of Medicine, UC Davis Comprehensive Cancer Center, Sacramento, California, USA